- Dosage: 100 IU/mL
- Volume: 3ml cartridge / vial
- Packaging: Sterile cartridge for injection, 3ml cartridge/tray*1 box
- Shelf Life: 36months
Package:
Product Description
Isophane Protamine Human Insulin 100IU/mL 3ml: What the Published Guidance Says
Human and analogue insulins alongside the oral hypoglycaemics and cardiorenal-metabolic agents added to the WHO Model List in its September 2025 revision.
Before Isophane Protamine Human Insulin 100IU/mL 3ml is quoted, we confirm the monograph, the strength on the artwork and the release testing required by your market — the points summarised here.
- The Model List details the insulin presentations and strengths Section 18.5.1 of the 24th WHO Model List (2025) lists human short-acting insulin as an injection solution of 40 IU/mL or 100 IU/mL in 10 mL vials and 100 IU/mL in 3 mL cartridges or pre-filled pens. Human intermediate-acting insulin is listed as an injection suspension in the same strengths, as compound insulin zinc suspension or isophane insulin. Long-acting and rapid-acting analogues are listed with glargine, degludec and detemir named among the therapeutic alternatives — a footnote notes that quality-assured biosimilars are included. WHO eEML — Medicines for diabetes
- The scale of the access problem WHO reports that more than 800 million people were living with diabetes in 2022, with half going untreated, and that more than one billion people worldwide are affected by obesity with rates rising fastest in low- and middle-income countries. WHO — Essential medicines list updated to include key cancer and diabetes treatments (5 Sep 2025)
- September 2025 added the GLP-1 class WHO added the GLP-1 receptor agonists semaglutide, dulaglutide and liraglutide, and the dual GLP-1/GIP agonist tirzepatide, for adults with type 2 diabetes where cardiovascular disease or chronic kidney disease is established and obesity is present (BMI ≥ 30 kg/m²). WHO — Essential medicines list updated to include key cancer and diabetes treatments (5 Sep 2025)
These points are quoted because they shape how Isophane Protamine Human Insulin 100IU/mL 3ml is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.
Supply & Specification Data for Isophane Protamine Human Insulin 100IU/mL 3ml
| Product Name | Isophane Protamine Human Insulin Injection (NPH Insulin / Neutral Protamine Hagedorn Insulin, Recombinant DNA Origin) |
| Specification | 100 IU/mL — 3mL Cartridge (300 IU total) |
| Dosage Form | Sterile, Nonpyrogenic, White to Off-White Aqueous Suspension for Subcutaneous Injection (intermediate-acting basal insulin) |
| Active Ingredient | Human Insulin (recombinant DNA origin) complexed with Protamine Sulfate and Zinc (isophane insulin suspension) |
| Pharmacological Class | Antidiabetic Agent / Pancreatic Hormone / Intermediate-Acting Basal Insulin (Blood Glucose Regulating Agent) |
| Route of Administration | Subcutaneous injection only (abdomen, thigh, deltoid, or buttock). NOT for intravenous or intramuscular injection. |
| Storage | Unopened: Store refrigerated at 2°C to 8°C, protected from light. Do NOT freeze. In-use (opened): Store at room temperature (below 25°C) for up to 28 days, away from direct heat and light. Discard after 28 days even if unused. |
| Therapeutic group | Diabetes & Insulin — Diabetes & Insulin |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Mixed Protamine Human Insulin 30R, Insulin Glargine Injection 100IU/mL 3ml Cartridge, Human Insulin Injection 3ml 300IU Cartridge & 10ml 1000IU Vial, Dapagliflozin 10mg Tablets, Canagliflozin 300mg Tablets, Empagliflozin 25mg Tablets, Ertugliflozin 15mg Tablets, Finerenone 20mg Tablets.
Testing, Monographs & Batch Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Isophane Protamine Human Insulin 100IU/mL 3ml is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
The batch record for this product normally includes:
- Testing for packaging integrity and seal testing
- Testing for description and identification
- Testing for assay of the active substance
- Testing for related substances and impurities
- Testing for dissolution or release profile (solid oral forms)
- Testing for uniformity of dosage units
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Pack Configuration, Artwork & Shipping Documents
- Pack size: 3mL glass cartridge (for use with compatible insulin pen devices). Non-standard pack sizes can be quoted against your artwork.
- Storage: Unopened: Store refrigerated at 2°C to 8°C, protected from light. Do NOT freeze. In-use (opened): Store at room temperature (below 25°C) for up to 28 days, away from direct heat and light. Discard after 28 days even if unused..
- Shelf life: 36 months (unopened, refrigerated). Stability data for the marketed pack is included in the dossier.
- Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
- Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.
Dossier, Authority Filings & Tender Documentation
Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.
- Site Master File and GMP certificate for the manufacturing workshops.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
- Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
- Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
This page describes Isophane Protamine Human Insulin 100IU/mL 3ml as a product of the medicines for diabetes listed in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.
Buyer Questions about Isophane Protamine Human Insulin 100IU/mL 3ml
What pack size is available for Isophane Protamine Human Insulin 100IU/mL 3ml?
The reference pack is 3mL glass cartridge (for use with compatible insulin pen devices). Non-standard blister, bottle and carton configurations are quoted against your artwork, matched to the stability data already held for the presentation.
What documentation comes with a shipment of Isophane Protamine Human Insulin 100IU/mL 3ml?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months.
Does the batch documentation for Isophane Protamine Human Insulin 100IU/mL 3ml support a registration filing?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Which SGLT2 inhibitors do you supply?
Empagliflozin, dapagliflozin, canagliflozin and ertugliflozin in tablet form. Empagliflozin is the molecule specifically listed in section 18.5.2 of the Model List, with canagliflozin and dapagliflozin named as therapeutic equivalents.
How is insulin shipped?
Under temperature-controlled conditions with shipment temperature records. Confirm the exact cold-chain specification required for your market before ordering.
Other Diabetes & Insulin Products in This Range
- Mixed Protamine Human Insulin 30R — 100IU
- Insulin Glargine Injection 100IU/mL 3ml Cartridge — 100IU
- Human Insulin Injection 3ml 300IU Cartridge & 10ml 1000IU Vial — 100IU
- Dapagliflozin 10mg Tablets — 10mg
- Canagliflozin 300mg Tablets — 300mg
- Empagliflozin 25mg Tablets — 25mg
Browse the full Diabetes & Insulin range; all Injectables; the complete product catalogue.
Request a Quotation for Isophane Protamine Human Insulin 100IU/mL 3ml
Send the specification, pack size, quantity and destination market for Isophane Protamine Human Insulin 100IU/mL 3ml 100IU and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.
Sources & Regulatory Notes
- WHO eEML — Medicines for diabetes
- WHO — Essential medicines list updated to include key cancer and diabetes treatments (5 Sep 2025)
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
